Exarmed Pharma Private Limited
Pharmaceutical company that markets, sources, and trades basic drugs and chemicals.
2019 | Medak, Telangana (India) | Converted to LLP
Exarmed Pharma Profile
Key Indicators
- Authorised Capital ₹ 13.50 Cr
- Paid Up Capital ₹ 13.50 Cr
- Company Age 6 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 109.07%
- Profit Growth 358.57%
- Ebitda 358.57%
- Net Worth 0.27%
- Total Assets 1.21%
About Exarmed Pharma
Exarmed Pharma Private Limited (EPPL) is Converted To Llp company established on 08 Jan 2019 with its office registered at Medak, Telangana, India and has been running since 6 Year, 3 Months with a paid up capital of 13.50 Cr. According to MCA records, 3 Directors and 1 Signatories are linked to this company as of 23 Oct 2024.
Company Details
- Location
Medak, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24110TG2019PTC129565
- Company No.
129565
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jan 2019
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
Exarmed Pharma Private Limited
Explore comprehensive data for Exarmed Pharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Exarmed Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ganamoor Reddy  | Company Secretary | 01-Nov-2022 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vajrala Bhulakshmi | Director | 08-Jan-2019 | Current |
| Jahnavi Puchakayala | Director | 08-Jan-2019 | Current |
| Bala Thippabhotla | Director | 01-Jul-2019 | Current |
Financial Performance of Exarmed Pharma.
Exarmed Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 109.07% increase. The company also saw a substantial improvement in profitability, with a 358.57% increase in profit. The company's net worth moved up by a moderate rise of 0.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Exarmed Pharma?
In 2023, Exarmed Pharma had a promoter holding of 65.79% and a public holding of 34.21%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Apogen Remedies Private LimitedBala Thippabhotla is a mutual person
- Bago Laboratories Private Limited
Bala Thippabhotla is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Exarmed Pharma?
Unlock and access historical data on people associated with Exarmed Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Exarmed Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Exarmed Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Exarmed Pharma
Recent activity within the organization
- Annual General Meeting
Exarmed Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
- Balance Sheet
Exarmed Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad.
- Director Appointment
Ganamoor Madhusudhan Reddy was appointed as a Company Secretary was appointed as a Company Secretary on 01 Nov 2022 & has been associated with this company since 2 years 5 months .
- Director Appointment
Bala Murali Krishna Thippabhotla was appointed as a Director was appointed as a Director on 01 Jul 2019 & has been associated with this company since 5 years 9 months .
- Director Appointment
Vajrala Bhulakshmi was appointed as a Director was appointed as a Director on 08 Jan 2019 & has been associated with this company since 6 years 3 months .
- Director Appointment
Jahnavi Puchakayala was appointed as a Director was appointed as a Director on 08 Jan 2019 & has been associated with this company since 6 years 3 months .
Frequently asked questions
What is the Incorporation or founding date of Exarmed Pharma Private Limited?
Exarmed Pharma Private Limited was incorporated on 08 Jan 2019.
What is authorized share capital and paid-up capital of Exarmed Pharma Private Limited?
The authorized share capital of Exarmed Pharma Private Limited is ₹ 13.50 Cr and paid-up capital is ₹ 13.50 Cr.
Who are the current board members & directors of Exarmed Pharma Private Limited?
Currently 4 directors are associated with Exarmed Pharma Private Limited.
- Ganamoor Madhusudhan Reddy
- Vajrala Bhulakshmi
- Jahnavi Puchakayala
- Bala Murali Krishna Thippabhotla
What is the registered address of Exarmed Pharma Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Exarmed Pharma Private Limited is Survey 321 Plot No. 55/A Biotech Park Phase Iii Tsiic Karakapatla Village Markook Mandal Siddipet District, India, Gujvail, Telangana, 502281.
What is the corporate identification number (CIN) and company number of Exarmed Pharma Private Limited?
The corporate identification number (CIN) of Exarmed Pharma Private Limited is U24110TG2019PTC129565 and the company number is 129565 as per Ministry of Corporate Affairs (MCA).
What has been the recent revenue trend for Exarmed Pharma Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Exarmed Pharma Private Limited has risen by 109.07%.
What change has been observed in the net worth of Exarmed Pharma Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Exarmed Pharma Private Limited has experienced an upsurge of 0.27%.
When was the last Balance Sheet of Exarmed Pharma Private Limited filed with the ROC?
The most recent Balance Sheet for Exarmed Pharma Private Limited was filed with the ROC on 31 Mar 2023.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records